Hearscape
← Organizations
Sponsor / Institution

University of Minnesota

Organization-level profile for a sponsor, institution, collaborator, or mixed-role entity. These profiles are separated from the primary industry company index when appropriate.

All ProgramsTherapeuticsDevices
Open filtered programs
Programs
3
linked to organization
Strong Evidence
0
0 status confirmed
Details Checked
3
0 open data checks
Company / Institution Links
0 / 3
industry vs non-industry records
Competitive Density
4
Pipeline Velocity
33
Completion Signal
33

Programs by Stage

Phase 21
Phase 31
Not applicable1

Trial / Program Status

Active1
Completed2

Modality Mix

Behavioral/Rehabilitation1
Biologic1
Hearing Aid/Software1

Indication Coverage

Hearing Loss2
Age-Related Hearing Loss1
Tinnitus1

Program Types

Procedure/Rehab1
Software/Neurotech1
Therapeutic1

Population Tags

adult2
age-related1
cognitive-health1
hearing-aid1
hearing-aid-user1
mild-to-moderate1
older-adult1
rehabilitation1
repurposed-drug1
tinnitus1

Strong-Evidence Records

0 records
No strong-evidence records are linked to this organization yet.

Checked Records With Caveats

3 checked · 0 open checks
Eargo self-fitting hearing aid validation study
Details checked
Hearing Aid/SoftwareNot applicableCompleted

Clinical validation of Eargo self-fitting gain software comparing app-guided self-fitting against audiologist fitting for adults with mild-to-moderate hearing loss.

Data checks: registry-only-evidence, industry-device-used-in-study
ACHIEVE brain-health hearing intervention follow-up study
Details checked
Behavioral/RehabilitationPhase 3Active

Active-not-recruiting Phase 3 follow-up to ACHIEVE evaluating long-term effects of best-practice hearing rehabilitation, including hearing aids and individualized audiology sessions, on cognitive decline and brain-health outcomes in older adults.

Data checks: institution-led-study, federal-sponsor
University of Minnesota incobotulinumtoxinA tinnitus study
Details checked
BiologicPhase 2Completed

Completed randomized Phase 2 trial evaluating incobotulinumtoxinA injections into auricular muscles for tinnitus relief using Tinnitus Handicap Inventory outcomes.

Data checks: institution-led-study, historical-completed-study